Recommended Antibiotics for Cellulitis
For non-purulent cellulitis, first-line treatment should be a 5-6 day course of antibiotics active against streptococci, specifically cephalexin (500mg orally 4 times daily), a penicillin, or clindamycin for penicillin-allergic patients. 1
First-Line Antibiotic Options
Standard Cases (Targeting Streptococci)
First choice oral options:
For penicillin-allergic patients:
- Clindamycin 1
First choice IV options (if needed):
- Cefazolin 1-2g IV every 8 hours 1
Duration of Therapy
- 5-6 days is sufficient for uncomplicated cellulitis in patients who can self-monitor and have close follow-up 2, 1
- Evidence from multiple studies supports shorter courses:
Special Considerations
When to Consider MRSA Coverage
Add coverage for MRSA when any of these risk factors are present:
- Penetrating trauma 1
- Evidence of MRSA infection elsewhere 2, 1
- Nasal colonization with MRSA 2, 1
- Injection drug use 2, 1
- Systemic inflammatory response syndrome 2, 1
- Purulent drainage 1
MRSA Coverage Options
Oral options:
IV options:
Treatment Algorithm
Assess severity and need for hospitalization:
- Hospitalize if: signs of systemic toxicity, altered mental status, hemodynamic instability, deeper infection concerns, poor adherence, or severely immunocompromised 1
- Otherwise, treat as outpatient
Determine if purulent or non-purulent:
- For purulent cellulitis: incision and drainage is primary treatment 1
- For non-purulent cellulitis: proceed with antibiotic selection
Select appropriate antibiotic:
- Standard case (no MRSA risk factors): Cephalexin, penicillin, or clindamycin (if penicillin-allergic)
- With MRSA risk factors: Add or switch to MRSA-active agent
Determine route:
- Oral therapy for mild-moderate cases
- IV therapy for severe cases or treatment failures
- Consider research showing oral therapy may be as effective as parenteral therapy for uncomplicated cases 5
Set duration:
- 5-6 days for uncomplicated cases with good response
- Consider extending to 10-14 days for immunocompromised patients, diabetics, severe infections, or slow clinical response 1
Monitoring and Follow-up
- Monitor daily for clinical response 1
- Consider extending treatment if infection has not improved after 5 days 2
- Transition from IV to oral therapy when improvement is observed 1
- Watch for complications such as abscess formation or progression to necrotizing fasciitis 1
Prevention of Recurrence
- For patients with 3-4 episodes per year, consider prophylactic antibiotics:
- Oral penicillin or erythromycin twice daily for 4-52 weeks
- Intramuscular benzathine penicillin every 2-4 weeks 1
- Identify and treat predisposing conditions (tinea pedis, venous eczema, trauma, edema, obesity) 1
Common Pitfalls to Avoid
- Inadequate dosing: Weight-based dosing is important for optimal outcomes; inadequate dosing has been independently associated with clinical failure 1
- Unnecessarily prolonged therapy: 5-6 days is sufficient for most uncomplicated cases 2, 1, 3
- Overuse of MRSA coverage: Standard streptococcal coverage is appropriate for most non-purulent cellulitis 2, 1
- Failure to drain purulent collections: Incision and drainage is the primary treatment for any abscess or purulent collection 1
- Missing underlying predisposing conditions: Address factors like tinea pedis or venous insufficiency to prevent recurrence 1